Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment.

According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria infections between 2027 and 2029.

Despite this compounding retreat, executive director Peter Sands praised the final tally as a “remarkable result, achieved in a challenging global context.”

Significant changes in global health financing have forced a strategic shift, introduced in late 2025, toward the poorest nations bearing the heaviest disease burdens, while placing middle-income countries on accelerated transition timelines toward national self-reliance.

“It’s our duty to steer the partnership through this period of uncertainty in a way that protects sustainability, preserves impact and ensures that the Global Fund continues to deliver for the people and communities we serve,” said Roslyn Morauta, chair of the Global Fund Board, at the 54th Board meeting in February 2026.

To manage the Global Fund shortfall, the board approved $10.78 billion in core country allocations for the 2027-2029 implementation period. To maximize the impact of the remaining funds, the board also earmarked $260 million for “catalytic investments” designed to expand access to innovative health products.

Executive leadership stressed the urgent need to prioritize these game-changing biomedical innovations, specifically highlighting the continued scale-up of the HIV prevention tool Lenacapavir, alongside new molecular diagnostics for tuberculosis and advanced vector control tools for malaria.

French budgetary constraints compound shortfall

The Global Fund shortfall is compounded by a broader shift towards fiscal restraint and budgetary scrutiny across major Western nations. France has traditionally stood as the second-largest contributor to the institution, having regularly increased its support with successive 20% bumps during the previous two replenishment cycles.

But, as first reported by franceinfo, the state has now decided to severely slash its international health budget, reducing its financial contribution by 58% for the upcoming cycle, down from the €1.6 billion it previously provided.

In a response to a query by Health Policy Watch, the Ministry for Europe and Foreign Affairs framed the retreat as a fiscal necessity, citing a mandate to cap the public deficit at 5% of Gross Domestic Product (GDP) by 2026, necessitating significant budgetary efforts across all government sectors.

Despite the cut signalling a shift in priorities, the ministry stressed that these temporary financial constraints should not be interpreted as a principled retreat from multilateralism.

“The reduction in French investments in global health must be understood in this context, which in no way calls into question our commitment in this area,” stated the Quai d’Orsay in its response.

As the pledge is yet to be finalised, the French government insists that global health remains a priority, with the ministry noting that health was recently confirmed as one of France’s “10 priority political objectives” for solidarity investments, specifically aimed at strengthening pandemic resilience and primary health systems.

The current intense budgetary pressure stems from the legislative instability currently gripping President Emmanuel Macron’s administration. After losing its parliamentary majority, the fragmented centrist government only managed to pass the 2026 budget by utilizing a special constitutional tool to bypass a standard vote.

EU caught in a budget deadlock

The impact of the Global Fund shortfall is exacerbated by the European Commission’s continued inability to pledge any commitments, a deadlock extending through the February 2026 board meeting.

The European bloc missed the formal November 2025 pledging summit, claiming it could not legally secure a multi-year pledge because the replenishment cycle falls between two long-term EU budgets, the Multiannual Financial Framework (MFF). The current MFF ends 2027, the new framework from 2028-2034 is yet to be formally adopted.

According to recent budget hearings, the European Commission formulated a workaround and intended to officially pledge €700 million over a four-year span at the February board meeting. However, the Commission experienced an ongoing delay in formalizing this pledge by the time the board convened, research by Health Policy Watch confirms.

This delay comes as the European Parliament warns of severe constraints and a “very limited level of availabilities'”as the bloc approaches the final year of its current 2021-2027 long-term budget.

EXCLUSIVE: EU to Pledge €700 Million to Global Fund, Less Than Previous Years

Even if this severely delayed pledge eventually materializes, stretching it over four years instead of three would represent a significant funding reduction of approximately 26.5% on an annualized basis. Furthermore, the European Commission has confirmed there will be no dedicated “health window” to ringfence budget appropriations in the upcoming long-term budget.

Other major donors had already drastically cut their contributions to the Global Fund, fundamentally altering the global health financing landscape. Driven primarily by an inward-looking “America First” political strategy, the US commitment fell from $6 billion in the seventh replenishment to just $4.6 billion in the eighth.

Private sector growth cannot counter cuts

Despite shortfall from major donors, the latest replenishment cycle yielded encouraging progress from alternative sources. The global private sector and various philanthropic organizations stepped forward, successfully mobilizing $1.34 billion for the eighth replenishment.

The Bill & Melinda Gates Foundation maintained its role as the premier private global donor by pledging $912 million. Other corporate actors stepped up to fund vital localized health initiatives, including a £6 million joint financial pledge  from GSK and ViiV Healthcare.

The Children’s Investment Fund Foundation (CIFF) pledged $50 million to accelerate the rollout of innovative tuberculosis diagnostics across affected regions. Goodbye Malaria also reaffirmed its leadership with a $5.5 million contribution to sustain targeted malaria elimination efforts in Eswatini, Mozambique, and South Africa.

However, while private funding sits at a record high, it cannot structurally replace the loss of sovereign anchor donors. Even with the $1.34 billion private surge, the overall replenishment total remains more than $5 billion short of the necessary goal to defeat these diseases.

African states stepping up

African states are stepping up, taking a larger financial stake in their health systems. Uganda maintained its previous funding levels with a $3 million pledge, which African diplomats celebrated as a powerful demonstration of the continent’s shared responsibility.

This contribution from Uganda is part of a broader, encouraging trend of African implementer-donors actively increasing their domestic financing. South Africa more than doubled its previous commitment to pledge $26.6 million, while Nigeria increased its pledge from $13.2 million to $15 million.

African diplomats have continually emphasized the critical importance of increased sovereign investment to accelerate health gains across the continent.

As the global health architecture enters this new era of austerity, the structural reliance on domestic African financing will inevitably grow. Despite the current Global Fund shortfall from the West, this emerging sovereign agency offers a resilient pathway toward long-term sustainability and equitable health outcomes.

Image Credits: WHO/Fanjan Combrink , Felix Sassmannshausen/Health Policy Watch, European Union.